Nabla Bio
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
About Nabla Bio
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $37,381,000
- Last Funding Type
- series_a
- Last Funding Date
- 2024-05-14
- Website
- nabla.bio
Industries & Categories
Biopharma, Biotechnology, Machine Learning
Social Links
Canonical: https://fsome.com/organization/nabla-bio-62640 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.